Special Issue "Marine Carotenoids and Oxidative Stress"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 March 2012)

Special Issue Editor

Guest Editor
Dr. Graziano Riccioni
Studio Medico Polispecialistico, Via Magenta 106, San Severo, 71016 Foggia, Italy
Website: http://www.docvadis.it/graziano.riccioni/index.html
E-Mail: griccioni@hotmail.com
Phone: +39 3664694444
Fax: +39 882227022
Interests: atherosclerosis; statins; ivabradine; ischemic cardiac disease; antioxidants; endothelial dyfunction and metabolities; carotenoids

Special Issue Information

Dear Colleagues,

Oxidative stress (OS) induced by reactive oxygen species (ROS) plays an important role in the aetiology of many diseases. Dietary phytochemical products such bioactive food components (alpha- and beta-carotene) and marine carotenoids (asthaxantin, lutein, β-carotene, fucoxanthin) have shown an antioxidant effect in reducing both oxidative markers stress. Scientifical evidences support the beneficial roles of phytochemicals in the prevention of some chronic diseases. Many carotenoids with great antioxidant properties have shown both in epidemiological studies and supplementation human trials a reduction of disease risk. However, controlled clinical trials and dietary intervention studies using well-defined subjects population haven't been provided a clear evidence of these substances in the prevention of diseases. In this special issue, the most important aspects will regard the synthesis, biological activities, and clinical applications of these carotenoids.

Dr. Graziano Riccioni
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).

Keywords

  • oxidative stress
  • reactive oxygen species
  • oxidation
  • marine carotenoids
  • lycopene
  • lutein
  • astaxanthin
  • zeaxanthin
  • β-carotene
  • fucoxanthin

Published Papers (9 papers)

Open Access
Mar. Drugs 2012, 10(1), 116-118; doi:10.3390/md10010116
Received: 6 January 2012 / Accepted: 11 January 2012 / Published: 16 January 2012
Show/Hide Abstract | Download PDF Full-text (133 KB) | Download XML Full-text

Open Access
Mar. Drugs 2012, 10(2), 403-416; doi:10.3390/md10020403
Received: 5 December 2011; in revised form: 6 February 2012 / Accepted: 6 February 2012 / Published: 15 February 2012
Show/Hide Abstract | Download PDF Full-text (683 KB) | Download XML Full-text

Open Access Free, Open Access Review Article
Mar. Drugs 2012, 10(3), 604-616; doi:10.3390/md10030604
Received: 29 December 2011; in revised form: 21 February 2012 / Accepted: 27 February 2012 / Published: 7 March 2012
Show/Hide Abstract | Download PDF Full-text (183 KB) | Download XML Full-text

Open Access Free, Open Access Review Article
Mar. Drugs 2012, 10(4), 812-833; doi:10.3390/md10040812
Received: 13 February 2012; in revised form: 15 March 2012 / Accepted: 23 March 2012 / Published: 5 April 2012
Show/Hide Abstract | Download PDF Full-text (235 KB) | Download XML Full-text

Open Access
Mar. Drugs 2012, 10(4), 890-899; doi:10.3390/md10040890
Received: 7 February 2012; in revised form: 22 March 2012 / Accepted: 1 April 2012 / Published: 10 April 2012
Show/Hide Abstract | Download PDF Full-text (352 KB) | Download XML Full-text

Open Access
Mar. Drugs 2012, 10(5), 998-1018; doi:10.3390/md10050998
Received: 12 March 2012; in revised form: 18 April 2012 / Accepted: 24 April 2012 / Published: 27 April 2012
Show/Hide Abstract | Download PDF Full-text (658 KB) | Download XML Full-text

Open Access
Mar. Drugs 2012, 10(6), 1391-1399; doi:10.3390/md10061391
Received: 29 March 2012; in revised form: 7 June 2012 / Accepted: 13 June 2012 / Published: 18 June 2012
Show/Hide Abstract | Download PDF Full-text (295 KB) | Download XML Full-text

Open Access
Mar. Drugs 2012, 10(6), 1400-1411; doi:10.3390/md10061400
Received: 3 April 2012; in revised form: 23 May 2012 / Accepted: 13 June 2012 / Published: 20 June 2012
Show/Hide Abstract | Download PDF Full-text (3118 KB) | Download XML Full-text

Open Access
Mar. Drugs 2012, 10(8), 1784-1798; doi:10.3390/md10081784
Received: 5 May 2012; in revised form: 7 July 2012 / Accepted: 25 July 2012 / Published: 20 August 2012
Show/Hide Abstract | Download PDF Full-text (445 KB) | Download XML Full-text | Supplementary Files

Last update: 10 October 2012

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert